Purchases and Sales Made in Q2 2022 in Revolution Medicines, Inc. (RVMD)
This table provides information about the institutional ownership of Revolution Medicines, Inc. (RVMD) during Q2 2022. The information is specifically focused on institutions that hold shares of Revolution Medicines, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 15, 2022
Q2 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-22.8K- 17.54% |
$332K - $619K
|
107K
$3.91M
|
|
Aug 15, 2022
Q2 2022
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-26.3K- 34.29% |
$383K - $716K
|
50.5K
$1.84M
|
|
Aug 15, 2022
Q2 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-28.4K- 12.57% |
$413K - $771K
|
197K
$7.2M
|
|
Aug 15, 2022
Q2 2022
|
Dark Forest Capital Management LP
Weston, CT |
SELL
|
- |
-29.3K- 99.7% |
$425K - $795K
|
89
$3.25K
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-35.4K- 64.31% |
$514K - $961K
|
19.6K
$716K
|
|
Aug 15, 2022
Q2 2022
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-44.7K- 66.04% |
$650K - $1.22M
|
23K
$839K
|
|
Aug 12, 2022
Q2 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-45.6K- 30.7% |
$663K - $1.24M
|
103K
$3.76M
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-49.1K- 54.48% |
$714K - $1.33M
|
41K
$1.5M
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-62K- 2.69% |
$901K - $1.68M
|
2.24M
$81.6M
|
|
Aug 15, 2022
Q2 2022
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-63.8K- 24.37% |
$928K - $1.73M
|
198K
$7.22M
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-86.4K- 61.31% |
$1.26M - $2.35M
|
54.5K
$1.99M
|
|
Aug 12, 2022
Q2 2022
|
Bollard Group LLC
Boston, MA |
SELL
|
- |
-86.8KClosed |
$1.26M - $2.36M
|
0
$0
|
|
Aug 12, 2022
Q2 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-105K- 49.92% |
$1.53M - $2.86M
|
105K
$3.85M
|
|
Aug 15, 2022
Q2 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-157KClosed |
$2.28M - $4.27M
|
0
$0
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-164K- 15.55% |
$2.38M - $4.45M
|
889K
$32.4M
|
|
Aug 15, 2022
Q2 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-364K- 92.94% |
$5.3M - $9.9M
|
27.7K
$1.01M
|
|
Aug 12, 2022
Q2 2022
|
Trv Gp Iii, LLC
Boston, MA |
SELL
|
- |
-420K- 7.6% |
$6.11M - $11.4M
|
5.1M
$186M
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-491K- 8.1% |
$7.14M - $13.3M
|
5.57M
$203M
|
|
Aug 15, 2022
Q2 2022
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-1.23MClosed |
$17.9M - $33.4M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-2.07M- 88.68% |
$30.1M - $56.2M
|
264K
$9.62M
|